Sea Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Cambridge, Massachusetts, United States • 1-10 Employees

Sea Pharmaceuticals revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,500,000
Total funding	$1,917,400

Key Contact at Sea Pharmaceuticals

James P Pearson

President, Ceo, Chief Science Officer Cso, Founder, Director Biologist And Pharmacologist

Company overview

Headquarters	Cambridge, Massachusetts, United States
Phone number	+16177949578
Website	seapharmaceuticals.com
NAICS	3254
Keywords	Neurology, Neuroscience, Tinnitus, Neuropsychiatry, Amyotrophic Lateral Sclerosis R&D, Central Nervous System Cns Disorders, Epilepsy Therapeutics Research And Development, Sporadic Als Research And Development, Synthetic Organic Discovery Chemistry, Tinnitus Therapeutics Research And Development, Als Therapeutics R&D, Constant Bothersome Tinnitus
Founded	2013
Employees	1-10
Socials

Sea Pharmaceuticals Email Formats

Sea Pharmaceuticals uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@seapharmaceuticals.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@seapharmaceuticals.com	100%

About Sea Pharmaceuticals

Privately held neurotherapeutics company founded in March 2013 by J.P. Pearson and E.J. Martinez and operated in Cambridge Massachusetts USA. Sea Pharmaceuticals LLC conducts research, development, and-commercialization (R-&-D-&-C) of Sea's novel proprietary synthetic small molecules targeting glutamate neurotransmitter system in neurology disorders. Sea is advancing orally administered potential treatments for high need constant bothersome tinnitus (CBT), Epilepsy, and sporadic Amyotrophic Lateral Sclerosis (S-ALS). Sea has 1 emeritus board member EBM & 7 board members. Benjamin F Cravatt PhD is Sea’s emeritus board member. Ben is neurochemist/ biologist Professor Scripps Research Institute and member NAS (USA National Academy Sciences); Ben founded >10 biotech co’s ActivX, Abide / Lundbeck, Vividion /Bayer, et al.; Sea's 7 board members: (i) Eric R Olson PhD molecular biologist, pharmacologist, trustee Cystic Fibrosis Foundation CFF; drug maker led R-&-D-&-C at Vertex VRTX to 4 life-saving CF drugs Kalydeco, Orkambi, Symdeco, Trikafta; former Aurora/ Vertex, Syros, Upjohn, Warner-Lambert/ Parke-Davis; (ii) Mark G Currie PhD molecular pharmacologist; on board IRWD; former CSO, President Ironwood Pharma Inc; Cyclerion Inc, Sepracor, Monsanto; Mark led R-&-D-&-C teams to drugs Celebrex, Bextra, Deramaxx (veterinary), Dynastat (Europe/Asia), Lunesta, Xopenex, Linzess / Constella (EU); (iii) W. Kendall Brown JD Cal-Tech trained physicist; lawyer Brown Associates Des Moines Iowa; computer scientist Advanced Logic Systems; IBM, California, (iv) Michael J Higgins MBA on several boards; was COO CFO Ironwood / Microbia; VP Genzyme, VP Procept); (v) Shaker Sadasivam PhD, MBA engineer formerly CEO Sun Edison Semi -Conductor (SEMI) Monsanto; on boards several co.; (vi) Nabil Elkouh PhD engineer, metals / batteries expert, CEO Conamix; Erigo Tech LLC, American Titanium Works (ATW); (vii) James P Pearson, President & CEO, Sea. See more at https://www.seapharmaceuticals.com

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Employees by Department

Sea Pharmaceuticals has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Sea Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-03-01	3	$1,500,000
2025-03-10	15	$417,400

Funding Insights

$1,917,400

Total funding amount

$417,400

Most recent funding amount

Number of funding rounds

Sea Pharmaceuticals Tech Stack

Discover the technologies and tools that power Sea Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

GoDaddy

Hosting

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Frequently asked questions

Sea Pharmaceuticals is located in Cambridge, Massachusetts, US.

You can reach Sea Pharmaceuticals at +16177949578.

Sea Pharmaceuticals generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.

Sea Pharmaceuticals has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Sea Pharmaceuticals was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Sea Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Sea Pharmaceuticals has raised a total of $1,917,400 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Sea Pharmaceuticals

James P Pearson

President, Ceo, Chief Science Officer Cso, Founder, Director Biologist And Pharmacologist

4.8

40,000 users